For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Novavax, Inc (NASDAQ: NVAX) was $5.43 for the day, down -19.56% from the previous closing price of $6.75. In other words, the price has decreased by -$19.56 from its previous closing price. On the day, 22.43 million shares were traded. NVAX stock price reached its highest trading level at $6.49 during the session, while it also had its lowest trading level at $5.01.
Ratios:
Our analysis of NVAX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 0.98.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on February 28, 2025, initiated with a Buy rating and assigned the stock a target price of $19.
On July 30, 2024, JP Morgan Downgraded its rating to Underweight which previously was Neutral but kept the price unchanged to $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 13 ’24 when King Rachel K. sold 4,150 shares for $9.02 per share. The transaction valued at 37,435 led to the insider holds 14,770 shares of the business.
YOUNG JAMES F sold 5,400 shares of NVAX for $43,200 on Dec 31 ’24. The Director now owns 51,760 shares after completing the transaction at $8.00 per share. On Dec 24 ’24, another insider, YOUNG JAMES F, who serves as the Director of the company, sold 4,600 shares for $8.48 each. As a result, the insider received 39,008 and left with 57,160 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 1088307712 and an Enterprise Value of 344020800. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.28. Its current Enterprise Value per Revenue stands at 0.504 whereas that against EBITDA is -1.875.
Stock Price History:
The Beta on a monthly basis for NVAX is 3.17, which has changed by 0.26869154 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is -28.78%, while the 200-Day Moving Average is calculated to be -46.78%.
Shares Statistics:
NVAX traded an average of 4.37M shares per day over the past three months and 8108570 shares per day over the past ten days. A total of 160.42M shares are outstanding, with a floating share count of 146.57M. Insiders hold about 8.87% of the company’s shares, while institutions hold 59.78% stake in the company. Shares short for NVAX as of 1741910400 were 37551429 with a Short Ratio of 8.45, compared to 1739491200 on 35447513. Therefore, it implies a Short% of Shares Outstanding of 37551429 and a Short% of Float of 29.09.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
